全球醫用推進劑市場

預計到 2030 年全球醫用推進劑市場規模將達 4.834 億美元

全球醫用推進劑市場規模預計在2024年為2.887億美元，到2030年將達到4.834億美元，在2024-2030年的分析期間內，複合年成長率為9.0%。本報告分析的細分市場之一HFA 134A預計複合年成長率為9.6%，到分析期結束時規模將達到2.665億美元。 HFA 227EA細分市場在分析期間的複合年成長率預計為7.6%。

美國市場規模估計為 7,860 萬美元，中國市場預計複合年成長率為 13.8%

美國醫用推進劑市場規模預計2024年達到7,860萬美元。作為世界第二大經濟體，中國市場規模預計到2030年將達到1.052億美元，在2024-2030年的分析期間內，複合年成長率為13.8%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個市場的複合年成長率分別為4.9%和8.2%。在歐洲，預計德國市場的複合年成長率約為6.4%。

全球醫用推進劑市場－主要趨勢與促進因素摘要

醫用推進劑如何實現拯救生命的治療？

醫用推進劑在呼吸系統藥物的輸送中起著至關重要的作用，尤其是透過定量吸入器 (MDI) 輸送，這使得它們對於治療氣喘、慢性阻塞性肺病(COPD) 和其他肺部疾病等慢性疾病至關重要。這些物質能夠將霧化藥物有效地直接輸送到肺部，使患者能夠快速獲得精確的劑量和藥效。與乾粉吸入器不同，以推進劑為基礎的 MDI 對兒童、老年人和嚴重病人特別有益，因為他們可能缺乏操作呼吸驅動裝置的吸氣力量。全球 MDI 的廣泛使用維持了對醫用級推進劑的持續需求，這類推進劑需要高純度、無毒和穩定。最新一代推進劑，例如氫氟烷 (HFA)，根據針對臭氧消耗物質的環境法規取代了氯氟烴 (CFC)。氫氟烷烴 (HFA) 因其安全性、不可燃性以及與多種活性藥物成分的兼容性而廣受認可。醫用推進劑不僅必須確保精準的藥物輸送，還必須在長期儲存過程中保持配方穩定性和設備性能。均勻穩定地分散細顆粒的能力是有效吸入療法的關鍵。隨著全球呼吸健康需求的持續成長，醫用推進劑在輸送救命治療藥物方面發揮的關鍵作用，正在強化其作為全球藥物輸送系統基本要素的作用。

環境問題和監管壓力如何改變醫療推進劑市場？

隨著人們環保意識的增強和全球法規結構的加強，醫藥推進劑產業正經歷重大變革時期。從歷史上看，基於氟氯化碳的推進劑曾廣泛用於吸入器，直到人們認知到它們的臭氧消耗效應，並透過《蒙特婁議定書》等協議實施國際禁令。這為氫氟烷的開發和應用鋪平了道路，氫氟烷對臭氧層無害，但具有相對較高的全球暖化潛勢值 (GWP)。因此，該行業目前正在尋求低 GWP 的 HFA 替代品，以提供相同的治療益處，而不會顯著導致氣候變遷。人們正在研究氫氟烯烴 (HFO) 等推進劑，因為它們在保持藥物輸送所需性能特徵的同時，可顯著降低 GWP 並具有環保特性。美國環保署和歐洲藥品管理局等監管機構正在透過政策指導和環境影響評估鼓勵製藥公司向更環保的推進劑過渡。製造商正在投資配方研究、設備相容性測試和毒性研究，以確保新型推進劑符合嚴格的安全性和有效性標準。這種轉變不僅關乎技術，也關乎經濟效益。挑戰在於如何在環境目標與患者可近性、可負擔性和治療可靠性之間取得平衡。隨著永續性成為醫療保健領域的關鍵標準，醫用推進劑向更綠色解決方案的演變勢在必行，對呼吸照護的未來至關重要。

臨床應用和設備相容性如何影響推進劑的選擇？

醫用推進劑的選擇在很大程度上取決於預期的臨床應用及其與藥物製劑和輸送裝置的兼容性。特別是，用於治療呼吸系統疾病的吸入器依賴推進劑的特定物理化學性質，以確保藥物均勻分散和精準給藥。合適的推進劑必須能夠溶解或懸浮活性藥物成分，而不會分解或改變藥物動力學。它還必須是惰性的，對呼吸道無刺激性，並且不含可能影響患者安全或監管核准的污染物。除了化學相容性之外，機械方面的考量也至關重要。推進劑必須與MDI裝置中使用的致動器、計量閥和容器有效配合，以確保一致的噴霧模式和粒徑分佈。這些特性直接影響藥物在肺部的沉積，最終影響治療的臨床療效。含有多種活性成分的聯合治療使配方更加複雜，需要仔細校準推進劑在壓力和長期條件下的行為。新興藥物類別和生技藥品也帶來了新的配方挑戰，影響著推進劑的開發。在獸醫學中，呼吸系統藥物也透過霧化途徑輸送，因此推進劑的兼容性仍然至關重要。此外，隨著遠端醫療和居家醫療服務的發展，依賴可靠推進劑的攜帶式、易於使用的吸入裝置也變得越來越重要。所有這些因素共同確保了醫用推進劑的選擇並非隨意，而是深植於配方科學和藥物輸送系統的力學原理。

推動全球醫用推進劑市場擴張的因素有哪些？

醫用推進劑市場的成長受到呼吸系統疾病盛行率上升、技術進步、監管變化和環境創新等多種因素的共同推動。首先，全球氣喘、慢性阻塞性肺病和過敏症盛行率的上升推動了對依賴推進劑有效輸送的吸入療法的需求。其次，氣霧劑科學和定量吸入器技術的進步正在擴大可供吸入的藥物範圍，從而擴大了推進劑市場。第三，老化和都市化等人口結構變化導致呼吸系統疾病負擔加重，特別是在空氣污染導致健康惡化的中低收入國家。第四，正在進行的製藥研發投資正在將現有藥物改造成可吸入形式，從而增加了對相容高效推進劑的需求。第五，監管部門不再關注高 GWP 物質，這推動了環境永續推進劑的創新，創造了一個專注於綠色化學和環境相容材料的新市場領域。第六，家庭醫療保健的擴展以及對攜帶式、易用治療設備的需求，推動了依賴可靠推進劑的微型吸入器系統的使用。第七，消費者對空氣品質和預防保健意識的不斷增強，鼓勵對呼吸系統疾病進行早期診斷和持續治療，從而推動了吸入器類藥物處方的增加。最後，製藥公司和設備製造商之間日益加強的合作，使得能夠共同開發既能最佳化治療效果又能最佳化環境永續性的藥物-設備組合。這些因素共同創造了一個充滿活力且不斷發展的市場環境，其中，「工業廢水」這個關鍵字依然存在，成為全球呼吸健康解決方案中一個經常被忽視但至關重要的組成部分。

部分

類型（HFA 134A、HFA 227EA、HFA-152A）、用途（按壓式定量吸入器、呼吸定量吸入器）、最終用途（醫療設備公司、契約製造組織、研究機構）

受訪公司範例

• Aeropres Corporation
• Arkema SA
• Avanti Polar Lipids（Croda）
• BOC Healthcare（Linde Group）
• Brothers Gas Bottling & Distribution LLC
• Central Gas Ventures
• Chemours Company
• DME Aerosol
• DuPont de Nemours, Inc.
• Honeywell International Inc.
• Linde plc
• Mexichem Fluor（Orbia Advance Corp.）
• MPI Research（Charles River）
• National Gases Ltd.
• Ningbo Fuluor Specialty Chemicals
• Solvay SA
• SRF Limited
• Tazzetti SpA
• TGV Group
• Zhejiang Sanmei Chemical Ind. Co.

人工智慧整合

全球產業分析師利用可操作的專家內容和人工智慧工具改變市場和競爭情報。

Global Industry Analysts 沒有遵循查詢 LLM 或特定產業SLM 的典型規範，而是建立了一個來自世界各地專家的精選內容庫，其中包括影片錄像、BLOG、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地和進出口（成品和原始設備製造商）情況預測其競爭地位的變化。這種複雜而多面的市場動態預計將以多種方式影響競爭對手，包括銷貨成本(COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

• 市場概覽
• 主要企業
• 市場趨勢和促進因素
• 全球市場展望

第3章市場分析

• 美國
• 加拿大
• 日本
• 中國
• 歐洲
• 法國
• 德國
• 義大利
• 英國
• 西班牙
• 俄羅斯
• 其他歐洲國家
• 亞太地區
• 澳洲
• 印度
• 韓國
• 其他亞太地區
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲
• 中東
• 伊朗
• 以色列
• 沙烏地阿拉伯
• 阿拉伯聯合大公國
• 其他中東地區
• 非洲

第4章 競賽

Global Medical Propellants Market to Reach US$483.4 Million by 2030

The global market for Medical Propellants estimated at US$288.7 Million in the year 2024, is expected to reach US$483.4 Million by 2030, growing at a CAGR of 9.0% over the analysis period 2024-2030. HFA 134A, one of the segments analyzed in the report, is expected to record a 9.6% CAGR and reach US$266.5 Million by the end of the analysis period. Growth in the HFA 227EA segment is estimated at 7.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$78.6 Million While China is Forecast to Grow at 13.8% CAGR

The Medical Propellants market in the U.S. is estimated at US$78.6 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$105.2 Million by the year 2030 trailing a CAGR of 13.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.9% and 8.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.4% CAGR.

Global Medical Propellants Market - Key Trends & Drivers Summarized

How Are Medical Propellants Enabling the Delivery of Life-Saving Therapies?

Medical propellants play a crucial role in the administration of respiratory drugs, particularly through metered-dose inhalers (MDIs), making them indispensable in treating chronic conditions such as asthma, chronic obstructive pulmonary disease (COPD), and other pulmonary disorders. These substances serve as the driving force behind the effective delivery of aerosolized medication directly into the lungs, allowing patients to receive precise dosages with rapid onset of action. Unlike dry powder inhalers, MDIs using propellants are especially beneficial for pediatric, elderly, and critically ill patients who may lack the inspiratory strength to operate breath-actuated devices. The widespread reliance on MDIs globally has sustained consistent demand for medical-grade propellants, which are required to be highly pure, non-toxic, and stable. The current generation of propellants, such as hydrofluoroalkanes (HFAs), replaced chlorofluorocarbons (CFCs) following environmental regulations targeting ozone-depleting substances. HFAs are widely recognized for their safety, non-flammability, and compatibility with a variety of active pharmaceutical ingredients. Medical propellants must not only ensure accurate drug delivery but also maintain formulation stability and device performance over prolonged storage. Their ability to disperse fine particles evenly and consistently is a cornerstone of effective inhalation therapy. As global respiratory health needs continue to rise, the essential function of medical propellants in delivering life-saving therapies reinforces their role as a fundamental element in drug delivery systems worldwide.

How Are Environmental Concerns and Regulatory Pressures Reshaping the Medical Propellants Market?

The medical propellants industry is undergoing significant transformation in response to growing environmental awareness and tightening global regulatory frameworks. Historically, chlorofluorocarbon-based propellants were widely used in inhalers until the realization of their ozone-depleting effects led to international bans under agreements such as the Montreal Protocol. This paved the way for the development and adoption of hydrofluoroalkanes, which do not harm the ozone layer but still carry a relatively high global warming potential (GWP). As a result, the industry is now exploring low-GWP alternatives to HFAs that can offer the same therapeutic efficacy without contributing substantially to climate change. Propellants such as hydrofluoroolefins (HFOs) are being investigated for their environmentally friendly profile, offering significantly reduced GWP while maintaining performance characteristics required for drug delivery. Regulatory bodies including the U.S. Environmental Protection Agency and the European Medicines Agency are encouraging pharmaceutical companies to transition to greener propellants through policy guidance and environmental impact assessments. Manufacturers are investing in reformulation research, device compatibility testing, and toxicity studies to ensure that new propellants meet stringent safety and efficacy standards. These shifts are not only technical but also economic, as companies must adapt their production facilities and supply chains to accommodate alternative substances. The challenge lies in balancing environmental goals with patient access, affordability, and therapeutic reliability. As sustainability becomes a key criterion in healthcare, the evolution of medical propellants toward greener solutions is both inevitable and pivotal for the future of respiratory care.

How Do Clinical Applications and Device Compatibility Influence Propellant Selection?

The selection of medical propellants is heavily influenced by the intended clinical applications and the compatibility of the propellant with drug formulations and delivery devices. Most notably, inhalers used in the treatment of respiratory diseases rely on specific physicochemical properties of propellants to ensure uniform drug dispersion and accurate dosing. A suitable propellant must be able to dissolve or suspend active pharmaceutical ingredients without causing degradation or changes in pharmacokinetics. It must also be inert, non-irritating to the respiratory tract, and free from contaminants that could impact patient safety or regulatory approval. In addition to chemical compatibility, mechanical considerations are paramount. The propellant must work effectively with the actuator, metering valve, and container used in the MDI device to ensure consistent spray pattern and particle size distribution. These characteristics directly impact the deposition of the drug in the lungs and, therefore, the clinical effectiveness of the therapy. For combination therapies involving multiple active ingredients, the formulation becomes even more complex, requiring careful calibration of propellant behavior under pressure and over time. Emerging drug classes and biologics also pose new formulation challenges that influence propellant development. In veterinary medicine, where respiratory therapies are also delivered through aerosolized routes, propellant compatibility remains critical. Furthermore, as telehealth and home care services grow, portable and user-friendly inhalation devices relying on dependable propellants are becoming increasingly important. All these factors combined ensure that the choice of a medical propellant is not arbitrary but deeply embedded in both the science of formulation and the mechanics of drug delivery systems.

What Factors Are Driving the Expansion of the Global Medical Propellants Market?

The growth in the medical propellants market is driven by a combination of rising respiratory disease prevalence, technological advancement, regulatory change, and environmental innovation. First, the increasing global incidence of asthma, COPD, and allergies is creating greater demand for inhalation therapies that rely on propellants for effective delivery. Second, advances in aerosol science and metered-dose inhaler technologies are expanding the scope of medications that can be administered via inhalation, leading to a broader market for propellants. Third, demographic changes such as aging populations and urbanization are contributing to a higher burden of respiratory illnesses, particularly in low- and middle-income countries where air pollution exacerbates health conditions. Fourth, ongoing pharmaceutical R&D investments are leading to the reformulation of existing drugs into inhalable forms, thereby increasing the need for compatible and efficient propellants. Fifth, regulatory shifts away from high-GWP substances are prompting innovation in environmentally sustainable propellants, creating new market segments focused on green chemistry and eco-compliant materials. Sixth, the expansion of home healthcare and the demand for portable, user-friendly therapeutic devices are boosting the use of compact inhaler systems that depend on reliable propellants. Seventh, heightened consumer awareness of air quality and preventive care is encouraging earlier diagnosis and consistent treatment of respiratory conditions, which in turn drives prescription volume for inhaler-based medications. Lastly, increased collaboration between pharmaceutical companies and device manufacturers is enabling the co-development of drug-device combinations that optimize both therapeutic outcomes and environmental sustainability. These combined factors are shaping a dynamic and evolving market landscape in which medical propellants remain a critical, though often overlooked, component of global respiratory health solutions.

SCOPE OF STUDY:

The report analyzes the Medical Propellants market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (HFA 134A, HFA 227EA, HFA-152A); Application (Press Metered Dose Inhalers Application, Breath Actuated Metered Dose Inhalers Application); End-Use (Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use, Research Laboratories End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 32 Featured) -

• Aeropres Corporation
• Arkema S.A.
• Avanti Polar Lipids (Croda)
• BOC Healthcare (Linde Group)
• Brothers Gas Bottling & Distribution LLC
• Central Gas Ventures
• Chemours Company
• DME Aerosol
• DuPont de Nemours, Inc.
• Honeywell International Inc.
• Linde plc
• Mexichem Fluor (Orbia Advance Corp.)
• MPI Research (Charles River)
• National Gases Ltd.
• Ningbo Fuluor Specialty Chemicals
• Solvay S.A.
• SRF Limited
• Tazzetti S.p.A.
• TGV Group
• Zhejiang Sanmei Chemical Ind. Co.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Medical Propellants - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Environmental Regulations and Phase-Out of High-GWP HFCs Throw the Spotlight on Next-Generation Low-Impact Medical Propellants
  • Rising Global Burden of Respiratory Diseases Propels Growth in Demand for Propellant-Based Inhalation Therapies
  • Shift Toward Patient-Friendly Drug Delivery Systems Expands the Addressable Market Opportunity for Pressurized MDIs
  • Approvals of New HFA Alternatives Strengthen the Business Case for Sustainable Medical Propellant Transitions
  • Inhaler Innovation for COPD and Asthma Management Accelerates Adoption of Optimized Propellant Formulations
  • Global Push to Meet Kigali Amendment Targets Spurs Urgency in Developing Eco-Conscious Medical Propellant Pipelines
  • Demand for Dose Consistency and Stability Generates Opportunities for Reformulated Propellant-Drug Combinations
  • Manufacturing Scale-Up for New Propellants Throws the Spotlight on Supply Chain Readiness and Fill-Finish Capabilities
  • Respiratory Therapy Access in Emerging Markets Sustains Growth of HFA-Based Propellants in Cost-Sensitive Regions
  • Digital Inhalers and Smart Devices Drive Innovation in Propellant Compatibility and Integration
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Medical Propellants Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Medical Propellants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Medical Propellants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 4: World 16-Year Perspective for Medical Propellants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for HFA 134A by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for HFA 134A by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 7: World 16-Year Perspective for HFA 134A by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for HFA 227EA by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for HFA 227EA by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 10: World 16-Year Perspective for HFA 227EA by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for HFA-152A by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for HFA-152A by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 13: World 16-Year Perspective for HFA-152A by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Press Metered Dose Inhalers Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Press Metered Dose Inhalers Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 16: World 16-Year Perspective for Press Metered Dose Inhalers Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Breath Actuated Metered Dose Inhalers Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Breath Actuated Metered Dose Inhalers Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 19: World 16-Year Perspective for Breath Actuated Metered Dose Inhalers Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Medical Device Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Medical Device Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 22: World 16-Year Perspective for Medical Device Companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Contract Manufacturing Organizations End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Contract Manufacturing Organizations End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 25: World 16-Year Perspective for Contract Manufacturing Organizations End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Research Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Research Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 28: World 16-Year Perspective for Research Laboratories End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Medical Propellants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 29: USA Recent Past, Current & Future Analysis for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 30: USA Historic Review for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 31: USA 16-Year Perspective for Medical Propellants by Type - Percentage Breakdown of Value Sales for HFA 134A, HFA 227EA and HFA-152A for the Years 2014, 2025 & 2030
  • TABLE 32: USA Recent Past, Current & Future Analysis for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 33: USA Historic Review for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 34: USA 16-Year Perspective for Medical Propellants by Application - Percentage Breakdown of Value Sales for Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application for the Years 2014, 2025 & 2030
  • TABLE 35: USA Recent Past, Current & Future Analysis for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 36: USA Historic Review for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 37: USA 16-Year Perspective for Medical Propellants by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use for the Years 2014, 2025 & 2030
• CANADA
  • TABLE 38: Canada Recent Past, Current & Future Analysis for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 39: Canada Historic Review for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 40: Canada 16-Year Perspective for Medical Propellants by Type - Percentage Breakdown of Value Sales for HFA 134A, HFA 227EA and HFA-152A for the Years 2014, 2025 & 2030
  • TABLE 41: Canada Recent Past, Current & Future Analysis for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 42: Canada Historic Review for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 43: Canada 16-Year Perspective for Medical Propellants by Application - Percentage Breakdown of Value Sales for Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application for the Years 2014, 2025 & 2030
  • TABLE 44: Canada Recent Past, Current & Future Analysis for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 45: Canada Historic Review for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 46: Canada 16-Year Perspective for Medical Propellants by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use for the Years 2014, 2025 & 2030
• JAPAN
  • Medical Propellants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 47: Japan Recent Past, Current & Future Analysis for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Japan Historic Review for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 49: Japan 16-Year Perspective for Medical Propellants by Type - Percentage Breakdown of Value Sales for HFA 134A, HFA 227EA and HFA-152A for the Years 2014, 2025 & 2030
  • TABLE 50: Japan Recent Past, Current & Future Analysis for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Japan Historic Review for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 52: Japan 16-Year Perspective for Medical Propellants by Application - Percentage Breakdown of Value Sales for Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application for the Years 2014, 2025 & 2030
  • TABLE 53: Japan Recent Past, Current & Future Analysis for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Japan Historic Review for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 55: Japan 16-Year Perspective for Medical Propellants by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use for the Years 2014, 2025 & 2030
• CHINA
  • Medical Propellants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 56: China Recent Past, Current & Future Analysis for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 57: China Historic Review for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 58: China 16-Year Perspective for Medical Propellants by Type - Percentage Breakdown of Value Sales for HFA 134A, HFA 227EA and HFA-152A for the Years 2014, 2025 & 2030
  • TABLE 59: China Recent Past, Current & Future Analysis for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 60: China Historic Review for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 61: China 16-Year Perspective for Medical Propellants by Application - Percentage Breakdown of Value Sales for Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application for the Years 2014, 2025 & 2030
  • TABLE 62: China Recent Past, Current & Future Analysis for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 63: China Historic Review for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 64: China 16-Year Perspective for Medical Propellants by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use for the Years 2014, 2025 & 2030
• EUROPE
  • Medical Propellants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 65: Europe Recent Past, Current & Future Analysis for Medical Propellants by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 66: Europe Historic Review for Medical Propellants by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 67: Europe 16-Year Perspective for Medical Propellants by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
  • TABLE 68: Europe Recent Past, Current & Future Analysis for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Europe Historic Review for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 70: Europe 16-Year Perspective for Medical Propellants by Type - Percentage Breakdown of Value Sales for HFA 134A, HFA 227EA and HFA-152A for the Years 2014, 2025 & 2030
  • TABLE 71: Europe Recent Past, Current & Future Analysis for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Europe Historic Review for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 73: Europe 16-Year Perspective for Medical Propellants by Application - Percentage Breakdown of Value Sales for Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application for the Years 2014, 2025 & 2030
  • TABLE 74: Europe Recent Past, Current & Future Analysis for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Europe Historic Review for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 76: Europe 16-Year Perspective for Medical Propellants by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use for the Years 2014, 2025 & 2030
• FRANCE
  • Medical Propellants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 77: France Recent Past, Current & Future Analysis for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 78: France Historic Review for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 79: France 16-Year Perspective for Medical Propellants by Type - Percentage Breakdown of Value Sales for HFA 134A, HFA 227EA and HFA-152A for the Years 2014, 2025 & 2030
  • TABLE 80: France Recent Past, Current & Future Analysis for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 81: France Historic Review for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 82: France 16-Year Perspective for Medical Propellants by Application - Percentage Breakdown of Value Sales for Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application for the Years 2014, 2025 & 2030
  • TABLE 83: France Recent Past, Current & Future Analysis for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 84: France Historic Review for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 85: France 16-Year Perspective for Medical Propellants by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use for the Years 2014, 2025 & 2030
• GERMANY
  • Medical Propellants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 86: Germany Recent Past, Current & Future Analysis for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Germany Historic Review for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 88: Germany 16-Year Perspective for Medical Propellants by Type - Percentage Breakdown of Value Sales for HFA 134A, HFA 227EA and HFA-152A for the Years 2014, 2025 & 2030
  • TABLE 89: Germany Recent Past, Current & Future Analysis for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Germany Historic Review for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 91: Germany 16-Year Perspective for Medical Propellants by Application - Percentage Breakdown of Value Sales for Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application for the Years 2014, 2025 & 2030
  • TABLE 92: Germany Recent Past, Current & Future Analysis for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Germany Historic Review for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 94: Germany 16-Year Perspective for Medical Propellants by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use for the Years 2014, 2025 & 2030
• ITALY
  • TABLE 95: Italy Recent Past, Current & Future Analysis for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Italy Historic Review for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 97: Italy 16-Year Perspective for Medical Propellants by Type - Percentage Breakdown of Value Sales for HFA 134A, HFA 227EA and HFA-152A for the Years 2014, 2025 & 2030
  • TABLE 98: Italy Recent Past, Current & Future Analysis for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Italy Historic Review for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 100: Italy 16-Year Perspective for Medical Propellants by Application - Percentage Breakdown of Value Sales for Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application for the Years 2014, 2025 & 2030
  • TABLE 101: Italy Recent Past, Current & Future Analysis for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Italy Historic Review for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 103: Italy 16-Year Perspective for Medical Propellants by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use for the Years 2014, 2025 & 2030
• UNITED KINGDOM
  • Medical Propellants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 104: UK Recent Past, Current & Future Analysis for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 105: UK Historic Review for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 106: UK 16-Year Perspective for Medical Propellants by Type - Percentage Breakdown of Value Sales for HFA 134A, HFA 227EA and HFA-152A for the Years 2014, 2025 & 2030
  • TABLE 107: UK Recent Past, Current & Future Analysis for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 108: UK Historic Review for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 109: UK 16-Year Perspective for Medical Propellants by Application - Percentage Breakdown of Value Sales for Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application for the Years 2014, 2025 & 2030
  • TABLE 110: UK Recent Past, Current & Future Analysis for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 111: UK Historic Review for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 112: UK 16-Year Perspective for Medical Propellants by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use for the Years 2014, 2025 & 2030
• SPAIN
  • TABLE 113: Spain Recent Past, Current & Future Analysis for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Spain Historic Review for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 115: Spain 16-Year Perspective for Medical Propellants by Type - Percentage Breakdown of Value Sales for HFA 134A, HFA 227EA and HFA-152A for the Years 2014, 2025 & 2030
  • TABLE 116: Spain Recent Past, Current & Future Analysis for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Spain Historic Review for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 118: Spain 16-Year Perspective for Medical Propellants by Application - Percentage Breakdown of Value Sales for Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application for the Years 2014, 2025 & 2030
  • TABLE 119: Spain Recent Past, Current & Future Analysis for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Spain Historic Review for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 121: Spain 16-Year Perspective for Medical Propellants by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use for the Years 2014, 2025 & 2030
• RUSSIA
  • TABLE 122: Russia Recent Past, Current & Future Analysis for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Russia Historic Review for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 124: Russia 16-Year Perspective for Medical Propellants by Type - Percentage Breakdown of Value Sales for HFA 134A, HFA 227EA and HFA-152A for the Years 2014, 2025 & 2030
  • TABLE 125: Russia Recent Past, Current & Future Analysis for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Russia Historic Review for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 127: Russia 16-Year Perspective for Medical Propellants by Application - Percentage Breakdown of Value Sales for Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application for the Years 2014, 2025 & 2030
  • TABLE 128: Russia Recent Past, Current & Future Analysis for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Russia Historic Review for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 130: Russia 16-Year Perspective for Medical Propellants by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use for the Years 2014, 2025 & 2030
• REST OF EUROPE
  • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Rest of Europe Historic Review for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 133: Rest of Europe 16-Year Perspective for Medical Propellants by Type - Percentage Breakdown of Value Sales for HFA 134A, HFA 227EA and HFA-152A for the Years 2014, 2025 & 2030
  • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Rest of Europe Historic Review for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 136: Rest of Europe 16-Year Perspective for Medical Propellants by Application - Percentage Breakdown of Value Sales for Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application for the Years 2014, 2025 & 2030
  • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Rest of Europe Historic Review for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 139: Rest of Europe 16-Year Perspective for Medical Propellants by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use for the Years 2014, 2025 & 2030
• ASIA-PACIFIC
  • Medical Propellants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Medical Propellants by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 141: Asia-Pacific Historic Review for Medical Propellants by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 142: Asia-Pacific 16-Year Perspective for Medical Propellants by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
  • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Asia-Pacific Historic Review for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 145: Asia-Pacific 16-Year Perspective for Medical Propellants by Type - Percentage Breakdown of Value Sales for HFA 134A, HFA 227EA and HFA-152A for the Years 2014, 2025 & 2030
  • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Asia-Pacific Historic Review for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 148: Asia-Pacific 16-Year Perspective for Medical Propellants by Application - Percentage Breakdown of Value Sales for Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application for the Years 2014, 2025 & 2030
  • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Asia-Pacific Historic Review for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 151: Asia-Pacific 16-Year Perspective for Medical Propellants by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use for the Years 2014, 2025 & 2030
• AUSTRALIA
  • Medical Propellants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 152: Australia Recent Past, Current & Future Analysis for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Australia Historic Review for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 154: Australia 16-Year Perspective for Medical Propellants by Type - Percentage Breakdown of Value Sales for HFA 134A, HFA 227EA and HFA-152A for the Years 2014, 2025 & 2030
  • TABLE 155: Australia Recent Past, Current & Future Analysis for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Australia Historic Review for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 157: Australia 16-Year Perspective for Medical Propellants by Application - Percentage Breakdown of Value Sales for Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application for the Years 2014, 2025 & 2030
  • TABLE 158: Australia Recent Past, Current & Future Analysis for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Australia Historic Review for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 160: Australia 16-Year Perspective for Medical Propellants by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use for the Years 2014, 2025 & 2030
• INDIA
  • Medical Propellants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 161: India Recent Past, Current & Future Analysis for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 162: India Historic Review for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 163: India 16-Year Perspective for Medical Propellants by Type - Percentage Breakdown of Value Sales for HFA 134A, HFA 227EA and HFA-152A for the Years 2014, 2025 & 2030
  • TABLE 164: India Recent Past, Current & Future Analysis for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 165: India Historic Review for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 166: India 16-Year Perspective for Medical Propellants by Application - Percentage Breakdown of Value Sales for Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application for the Years 2014, 2025 & 2030
  • TABLE 167: India Recent Past, Current & Future Analysis for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 168: India Historic Review for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 169: India 16-Year Perspective for Medical Propellants by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use for the Years 2014, 2025 & 2030
• SOUTH KOREA
  • TABLE 170: South Korea Recent Past, Current & Future Analysis for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 171: South Korea Historic Review for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 172: South Korea 16-Year Perspective for Medical Propellants by Type - Percentage Breakdown of Value Sales for HFA 134A, HFA 227EA and HFA-152A for the Years 2014, 2025 & 2030
  • TABLE 173: South Korea Recent Past, Current & Future Analysis for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 174: South Korea Historic Review for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 175: South Korea 16-Year Perspective for Medical Propellants by Application - Percentage Breakdown of Value Sales for Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application for the Years 2014, 2025 & 2030
  • TABLE 176: South Korea Recent Past, Current & Future Analysis for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 177: South Korea Historic Review for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 178: South Korea 16-Year Perspective for Medical Propellants by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use for the Years 2014, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 179: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Rest of Asia-Pacific Historic Review for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 181: Rest of Asia-Pacific 16-Year Perspective for Medical Propellants by Type - Percentage Breakdown of Value Sales for HFA 134A, HFA 227EA and HFA-152A for the Years 2014, 2025 & 2030
  • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Rest of Asia-Pacific Historic Review for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 184: Rest of Asia-Pacific 16-Year Perspective for Medical Propellants by Application - Percentage Breakdown of Value Sales for Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application for the Years 2014, 2025 & 2030
  • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Rest of Asia-Pacific Historic Review for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 187: Rest of Asia-Pacific 16-Year Perspective for Medical Propellants by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use for the Years 2014, 2025 & 2030
• LATIN AMERICA
  • Medical Propellants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 188: Latin America Recent Past, Current & Future Analysis for Medical Propellants by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 189: Latin America Historic Review for Medical Propellants by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 190: Latin America 16-Year Perspective for Medical Propellants by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
  • TABLE 191: Latin America Recent Past, Current & Future Analysis for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Latin America Historic Review for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 193: Latin America 16-Year Perspective for Medical Propellants by Type - Percentage Breakdown of Value Sales for HFA 134A, HFA 227EA and HFA-152A for the Years 2014, 2025 & 2030
  • TABLE 194: Latin America Recent Past, Current & Future Analysis for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Latin America Historic Review for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 196: Latin America 16-Year Perspective for Medical Propellants by Application - Percentage Breakdown of Value Sales for Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application for the Years 2014, 2025 & 2030
  • TABLE 197: Latin America Recent Past, Current & Future Analysis for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Latin America Historic Review for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 199: Latin America 16-Year Perspective for Medical Propellants by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use for the Years 2014, 2025 & 2030
• ARGENTINA
  • TABLE 200: Argentina Recent Past, Current & Future Analysis for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Argentina Historic Review for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 202: Argentina 16-Year Perspective for Medical Propellants by Type - Percentage Breakdown of Value Sales for HFA 134A, HFA 227EA and HFA-152A for the Years 2014, 2025 & 2030
  • TABLE 203: Argentina Recent Past, Current & Future Analysis for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Argentina Historic Review for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 205: Argentina 16-Year Perspective for Medical Propellants by Application - Percentage Breakdown of Value Sales for Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application for the Years 2014, 2025 & 2030
  • TABLE 206: Argentina Recent Past, Current & Future Analysis for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Argentina Historic Review for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 208: Argentina 16-Year Perspective for Medical Propellants by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use for the Years 2014, 2025 & 2030
• BRAZIL
  • TABLE 209: Brazil Recent Past, Current & Future Analysis for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Brazil Historic Review for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 211: Brazil 16-Year Perspective for Medical Propellants by Type - Percentage Breakdown of Value Sales for HFA 134A, HFA 227EA and HFA-152A for the Years 2014, 2025 & 2030
  • TABLE 212: Brazil Recent Past, Current & Future Analysis for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Brazil Historic Review for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 214: Brazil 16-Year Perspective for Medical Propellants by Application - Percentage Breakdown of Value Sales for Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application for the Years 2014, 2025 & 2030
  • TABLE 215: Brazil Recent Past, Current & Future Analysis for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Brazil Historic Review for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 217: Brazil 16-Year Perspective for Medical Propellants by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use for the Years 2014, 2025 & 2030
• MEXICO
  • TABLE 218: Mexico Recent Past, Current & Future Analysis for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Mexico Historic Review for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 220: Mexico 16-Year Perspective for Medical Propellants by Type - Percentage Breakdown of Value Sales for HFA 134A, HFA 227EA and HFA-152A for the Years 2014, 2025 & 2030
  • TABLE 221: Mexico Recent Past, Current & Future Analysis for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Mexico Historic Review for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 223: Mexico 16-Year Perspective for Medical Propellants by Application - Percentage Breakdown of Value Sales for Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application for the Years 2014, 2025 & 2030
  • TABLE 224: Mexico Recent Past, Current & Future Analysis for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Mexico Historic Review for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 226: Mexico 16-Year Perspective for Medical Propellants by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use for the Years 2014, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 227: Rest of Latin America Recent Past, Current & Future Analysis for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Rest of Latin America Historic Review for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 229: Rest of Latin America 16-Year Perspective for Medical Propellants by Type - Percentage Breakdown of Value Sales for HFA 134A, HFA 227EA and HFA-152A for the Years 2014, 2025 & 2030
  • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Rest of Latin America Historic Review for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 232: Rest of Latin America 16-Year Perspective for Medical Propellants by Application - Percentage Breakdown of Value Sales for Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application for the Years 2014, 2025 & 2030
  • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Rest of Latin America Historic Review for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 235: Rest of Latin America 16-Year Perspective for Medical Propellants by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use for the Years 2014, 2025 & 2030
• MIDDLE EAST
  • Medical Propellants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 236: Middle East Recent Past, Current & Future Analysis for Medical Propellants by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 237: Middle East Historic Review for Medical Propellants by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 238: Middle East 16-Year Perspective for Medical Propellants by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
  • TABLE 239: Middle East Recent Past, Current & Future Analysis for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Middle East Historic Review for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 241: Middle East 16-Year Perspective for Medical Propellants by Type - Percentage Breakdown of Value Sales for HFA 134A, HFA 227EA and HFA-152A for the Years 2014, 2025 & 2030
  • TABLE 242: Middle East Recent Past, Current & Future Analysis for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Middle East Historic Review for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 244: Middle East 16-Year Perspective for Medical Propellants by Application - Percentage Breakdown of Value Sales for Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application for the Years 2014, 2025 & 2030
  • TABLE 245: Middle East Recent Past, Current & Future Analysis for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Middle East Historic Review for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 247: Middle East 16-Year Perspective for Medical Propellants by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use for the Years 2014, 2025 & 2030
• IRAN
  • TABLE 248: Iran Recent Past, Current & Future Analysis for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Iran Historic Review for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 250: Iran 16-Year Perspective for Medical Propellants by Type - Percentage Breakdown of Value Sales for HFA 134A, HFA 227EA and HFA-152A for the Years 2014, 2025 & 2030
  • TABLE 251: Iran Recent Past, Current & Future Analysis for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Iran Historic Review for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 253: Iran 16-Year Perspective for Medical Propellants by Application - Percentage Breakdown of Value Sales for Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application for the Years 2014, 2025 & 2030
  • TABLE 254: Iran Recent Past, Current & Future Analysis for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Iran Historic Review for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 256: Iran 16-Year Perspective for Medical Propellants by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use for the Years 2014, 2025 & 2030
• ISRAEL
  • TABLE 257: Israel Recent Past, Current & Future Analysis for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Israel Historic Review for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 259: Israel 16-Year Perspective for Medical Propellants by Type - Percentage Breakdown of Value Sales for HFA 134A, HFA 227EA and HFA-152A for the Years 2014, 2025 & 2030
  • TABLE 260: Israel Recent Past, Current & Future Analysis for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Israel Historic Review for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 262: Israel 16-Year Perspective for Medical Propellants by Application - Percentage Breakdown of Value Sales for Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application for the Years 2014, 2025 & 2030
  • TABLE 263: Israel Recent Past, Current & Future Analysis for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Israel Historic Review for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 265: Israel 16-Year Perspective for Medical Propellants by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use for the Years 2014, 2025 & 2030
• SAUDI ARABIA
  • TABLE 266: Saudi Arabia Recent Past, Current & Future Analysis for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Saudi Arabia Historic Review for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 268: Saudi Arabia 16-Year Perspective for Medical Propellants by Type - Percentage Breakdown of Value Sales for HFA 134A, HFA 227EA and HFA-152A for the Years 2014, 2025 & 2030
  • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Saudi Arabia Historic Review for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 271: Saudi Arabia 16-Year Perspective for Medical Propellants by Application - Percentage Breakdown of Value Sales for Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application for the Years 2014, 2025 & 2030
  • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Saudi Arabia Historic Review for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 274: Saudi Arabia 16-Year Perspective for Medical Propellants by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use for the Years 2014, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 275: UAE Recent Past, Current & Future Analysis for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 276: UAE Historic Review for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 277: UAE 16-Year Perspective for Medical Propellants by Type - Percentage Breakdown of Value Sales for HFA 134A, HFA 227EA and HFA-152A for the Years 2014, 2025 & 2030
  • TABLE 278: UAE Recent Past, Current & Future Analysis for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 279: UAE Historic Review for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 280: UAE 16-Year Perspective for Medical Propellants by Application - Percentage Breakdown of Value Sales for Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application for the Years 2014, 2025 & 2030
  • TABLE 281: UAE Recent Past, Current & Future Analysis for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 282: UAE Historic Review for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 283: UAE 16-Year Perspective for Medical Propellants by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use for the Years 2014, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 284: Rest of Middle East Recent Past, Current & Future Analysis for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Rest of Middle East Historic Review for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 286: Rest of Middle East 16-Year Perspective for Medical Propellants by Type - Percentage Breakdown of Value Sales for HFA 134A, HFA 227EA and HFA-152A for the Years 2014, 2025 & 2030
  • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Rest of Middle East Historic Review for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 289: Rest of Middle East 16-Year Perspective for Medical Propellants by Application - Percentage Breakdown of Value Sales for Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application for the Years 2014, 2025 & 2030
  • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Rest of Middle East Historic Review for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 292: Rest of Middle East 16-Year Perspective for Medical Propellants by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use for the Years 2014, 2025 & 2030
• AFRICA
  • Medical Propellants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 293: Africa Recent Past, Current & Future Analysis for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Africa Historic Review for Medical Propellants by Type - HFA 134A, HFA 227EA and HFA-152A Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 295: Africa 16-Year Perspective for Medical Propellants by Type - Percentage Breakdown of Value Sales for HFA 134A, HFA 227EA and HFA-152A for the Years 2014, 2025 & 2030
  • TABLE 296: Africa Recent Past, Current & Future Analysis for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Africa Historic Review for Medical Propellants by Application - Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 298: Africa 16-Year Perspective for Medical Propellants by Application - Percentage Breakdown of Value Sales for Press Metered Dose Inhalers Application and Breath Actuated Metered Dose Inhalers Application for the Years 2014, 2025 & 2030
  • TABLE 299: Africa Recent Past, Current & Future Analysis for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Africa Historic Review for Medical Propellants by End-Use - Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 301: Africa 16-Year Perspective for Medical Propellants by End-Use - Percentage Breakdown of Value Sales for Medical Device Companies End-Use, Contract Manufacturing Organizations End-Use and Research Laboratories End-Use for the Years 2014, 2025 & 2030

IV. COMPETITION